Skip to main content
. 2019 Apr;11(4):1303–1315. doi: 10.21037/jtd.2019.03.99

Table 4. Demographic and clinical characteristics of the COPD patients who were reclassified from GOLD group D to B and the COPD patients remaining in group D.

Subjects DB (N=285) DD (N=619) P value
Age (years), mean ± SD 61.6±8.1 63.1±8.4 0.009
Male, n (%) 261 (91.6) 564 (91.1) 0.818
BMI (kg/m2), mean ± SD 21.9±3.4 21.9±3.4 0.957
Smoking pack-years* 30.0 (30.0) 30.0 (30.0) 0.341
FEV1% predicted, mean ± SD 36.9±8.7 46.5±17.5 <0.001
FEV1/FVC, mean ± SD 40.6±9.8 46.2±11.7 <0.001
mMRC, n (%) 0.013
   0 9 (3.2) 16 (2.6)
   1 66 (23.2) 92 (14.9)
   2 102 (35.8) 238 (38.4)
   3 89 (31.2) 229 (37.0)
   4 19 (6.7) 44 (7.1)
CAT, n (%) 0.001
   0–10 22 (7.7) 43 (6.9)
   11–20 196 (68.8) 382 (61.7)
   21–30 63 (22.1) 180 (29.1)
   31–40 4 (1.4) 14 (2.3)

*, Non-normal distribution data were expressed as median (interquartile range). DB, patients switched from group D to B; DD, patients remaining in group D; SD, standard deviation; BMI, body mass index; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; mMRC, modified Medical Research Council; CAT, COPD Assessment Test; COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Pulmonary Disease.